National Health Investors, Inc. (NYSE:NHI) was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday.

Other analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of National Health Investors from a “hold” rating to a “buy” rating and set a $86.00 target price on the stock in a report on Friday. BidaskClub cut shares of National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. BMO Capital Markets reissued a “hold” rating and set a $80.00 target price on shares of National Health Investors in a report on Wednesday, October 18th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $82.00 target price on shares of National Health Investors in a report on Wednesday, October 4th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $80.14.

Shares of National Health Investors (NYSE:NHI) traded up $0.23 during trading hours on Friday, hitting $76.66. 223,200 shares of the company’s stock were exchanged, compared to its average volume of 192,348. The firm has a market capitalization of $3,183.84, a PE ratio of 14.71, a price-to-earnings-growth ratio of 3.79 and a beta of 0.58. National Health Investors has a 52 week low of $67.33 and a 52 week high of $81.21. The company has a quick ratio of 12.45, a current ratio of 12.72 and a debt-to-equity ratio of 0.84.

National Health Investors (NYSE:NHI) last issued its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). The business had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a return on equity of 12.74% and a net margin of 59.70%. The firm’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same period last year, the company posted $1.22 earnings per share. sell-side analysts predict that National Health Investors will post 5.25 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/national-health-investors-inc-nhi-stock-rating-upgraded-by-valuengine/1698774.html.

In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the firm’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the transaction, the insider now directly owns 21,228 shares in the company, valued at $1,693,994.40. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 5.19% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Legal & General Group Plc lifted its position in shares of National Health Investors by 13.9% in the third quarter. Legal & General Group Plc now owns 116,146 shares of the real estate investment trust’s stock worth $8,980,000 after purchasing an additional 14,142 shares in the last quarter. American International Group Inc. lifted its position in shares of National Health Investors by 8.1% in the third quarter. American International Group Inc. now owns 26,648 shares of the real estate investment trust’s stock worth $2,060,000 after purchasing an additional 1,993 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of National Health Investors by 11.7% in the third quarter. Pacer Advisors Inc. now owns 7,402 shares of the real estate investment trust’s stock worth $572,000 after purchasing an additional 775 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of National Health Investors in the third quarter worth approximately $249,000. Finally, Ameriprise Financial Inc. lifted its position in shares of National Health Investors by 46.6% in the third quarter. Ameriprise Financial Inc. now owns 78,030 shares of the real estate investment trust’s stock worth $6,034,000 after purchasing an additional 24,790 shares in the last quarter. 70.13% of the stock is owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.